{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:16:43Z","timestamp":1726762603314},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00108-021-01208-5","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T19:13:22Z","timestamp":1638299602000},"page":"25-33","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Das Conn-Syndrom\u00a0\u2013 h\u00e4ufig, und immer noch zu selten diagnostiziert"],"prefix":"10.1007","volume":"63","author":[{"given":"Carmina T.","family":"Fuss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Adolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"1208_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone\u00a0S, Burrello\u00a0J, Tizzani\u00a0D, Bertello\u00a0C, Viola\u00a0A, Buffolo\u00a0F, Gabetti\u00a0L, Mengozzi\u00a0G, Williams\u00a0TA, Rabbia\u00a0F, Veglio\u00a0F, Mulatero\u00a0P (2017) Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J\u00a0Am Coll Cardiol 69:1811\u20131820","journal-title":"J Am Coll Cardiol"},{"key":"1208_CR2","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","volume":"101","author":"SC Kayser","year":"2016","unstructured":"Kayser\u00a0SC, Dekkers\u00a0T, Groenewoud\u00a0HJ, van der Wilt\u00a0GJ, Carel Bakx\u00a0J, van der Wel\u00a0MC, Hermus\u00a0AR, Lenders\u00a0JW, Deinum\u00a0J (2016) Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J\u00a0Clin Endocrinol Metab 101:2826\u20132835","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1055\/s-0043-119755","volume":"49","author":"F Buffolo","year":"2017","unstructured":"Buffolo\u00a0F, Monticone\u00a0S, Burrello\u00a0J, Tetti\u00a0M, Veglio\u00a0F, Williams\u00a0TA, Mulatero\u00a0P (2017) Is primary aldosteronism still largely unrecognized? Horm Metab Res 49:908\u2013914","journal-title":"Horm Metab Res"},{"key":"1208_CR4","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn\u00a0JW (1955) Presidential address. I. Painting background. II. Primary aldosteronism, a\u00a0new clinical syndrome. J\u00a0Lab Clin Med 45:3\u201317","journal-title":"J Lab Clin Med"},{"key":"1208_CR5","series-title":"Versorgungsatlas-Bericht","volume-title":"Diagnosepr\u00e4valenz der Hypertonie in der vertrags\u00e4rztlichen Versorgung \u2013 aktuelle deutschlandweite Kennzahlen","author":"J Holstiege","year":"2020","unstructured":"Holstiege\u00a0J, Akmatov\u00a0M, Steffen\u00a0A, B\u00e4tzing\u00a0J (2020) Diagnosepr\u00e4valenz der Hypertonie in der vertrags\u00e4rztlichen Versorgung \u2013 aktuelle deutschlandweite Kennzahlen. Versorgungsatlas-Bericht, Bd. 20\/01. Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in Deutschland, Berlin"},{"key":"1208_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7326\/M20-4873","volume":"174","author":"JB Cohen","year":"2021","unstructured":"Cohen\u00a0JB, Cohen\u00a0DL, Herman\u00a0DS, Leppert\u00a0JT, Byrd\u00a0JB, Bhalla\u00a0V (2021) Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans: a retrospective cohort study. Ann Intern Med 174:289\u2013297","journal-title":"Ann Intern Med"},{"key":"1208_CR7","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder\u00a0JW, Carey\u00a0RM, Mantero\u00a0F, Murad\u00a0MH, Reincke\u00a0M, Shibata\u00a0H, Stowasser\u00a0M, Young\u00a0WF Jr (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab 101:1889\u20131916","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1208_CR8","first-page":"A-184 \/ B-169 \/","volume":"100","author":"M Reincke","year":"2003","unstructured":"Reincke\u00a0M, Seiler\u00a0L, Rump\u00a0LC (2003) Normokali\u00e4mischer prim\u00e4rer Hyperaldosteronismus. Dtsch Arztebl 100(4):A-184 \/ B\u2011169 \/ C\u2011165","journal-title":"Dtsch Arztebl"},{"key":"1208_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone\u00a0S, D\u2019Ascenzo\u00a0F, Moretti\u00a0C, Williams\u00a0TA, Veglio\u00a0F, Gaita\u00a0F, Mulatero\u00a0P (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a\u00a0systematic review and meta-analysis. Lancet Diabetes Endocrinol 6:41\u201350","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1208_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno\u00a0Y, Sone\u00a0M, Inagaki\u00a0N, Yamasaki\u00a0T, Ogawa\u00a0O, Takeda\u00a0Y, Kurihara\u00a0I, Itoh\u00a0H, Umakoshi\u00a0H, Tsuiki\u00a0M, Ichijo\u00a0T, Katabami\u00a0T, Tanaka\u00a0Y, Wada\u00a0N, Shibayama\u00a0Y, Yoshimoto\u00a0T, Ogawa\u00a0Y, Kawashima\u00a0J, Takahashi\u00a0K, Fujita\u00a0M, Watanabe\u00a0M, Matsuda\u00a0Y, Kobayashi\u00a0H, Shibata\u00a0H, Kamemura\u00a0K, Otsuki\u00a0M, Fujii\u00a0Y, Yamamoto\u00a0K, Ogo\u00a0A, Okamura\u00a0S, Miyauchi\u00a0S, Fukuoka\u00a0T, Izawa\u00a0S, Yoneda\u00a0T, Hashimoto\u00a0S, Yanase\u00a0T, Suzuki\u00a0T, Kawamura\u00a0T, Tabara\u00a0Y, Matsuda\u00a0F, Naruse\u00a0M, Nagahama\u00a0S (2018) Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71:530\u2013537","journal-title":"Hypertension"},{"key":"1208_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1055\/s-0035-1565208","volume":"47","author":"H Remde","year":"2015","unstructured":"Remde\u00a0H, Hanslik\u00a0G, Rayes\u00a0N, Quinkler\u00a0M (2015) Glucose metabolism in primary aldosteronism. Horm Metab Res 47:987\u2013993","journal-title":"Horm Metab Res"},{"key":"1208_CR12","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.jpsychires.2012.08.025","volume":"46","author":"HE Kunzel","year":"2012","unstructured":"Kunzel\u00a0HE, Apostolopoulou\u00a0K, Pallauf\u00a0A, Gerum\u00a0S, Merkle\u00a0K, Schulz\u00a0S, Fischer\u00a0E, Brand\u00a0V, Bidlingmaier\u00a0M, Endres\u00a0S, Beuschlein\u00a0F, Reincke\u00a0M (2012) Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone. J\u00a0Psychiatr Res 46:1650\u20131654","journal-title":"J Psychiatr Res"},{"key":"1208_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpsychires.2020.07.006","volume":"130","author":"H Murck","year":"2020","unstructured":"Murck\u00a0H, Schlageter\u00a0L, Schneider\u00a0A, Adolf\u00a0C, Heinrich\u00a0D, Quinkler\u00a0M, Beuschlein\u00a0F, Reincke\u00a0M, Kunzel\u00a0H (2020) The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression\u2014lessons from primary aldosteronism. J\u00a0Psychiatr Res 130:82\u201388","journal-title":"J Psychiatr Res"},{"key":"1208_CR14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00299","author":"J Gerards","year":"2019","unstructured":"Gerards\u00a0J, Heinrich\u00a0DA, Adolf\u00a0C, Meisinger\u00a0C, Rathmann\u00a0W, Sturm\u00a0L, Nirschl\u00a0N, Bidlingmaier\u00a0M, Beuschlein\u00a0F, Thorand\u00a0B, Peters\u00a0A, Reincke\u00a0M, Roden\u00a0M, Quinkler\u00a0M (2019) Impaired glucose metabolism in primary aldosteronism is associated with cortisol co-secretion. J\u00a0Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2019-00299","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1208_CR15","doi-asserted-by":"publisher","first-page":"e93136","DOI":"10.1172\/jci.insight.93136","volume":"2","author":"W Arlt","year":"2017","unstructured":"Arlt\u00a0W, Lang\u00a0K, Sitch\u00a0AJ, Dietz\u00a0AS, Rhayem\u00a0Y, Bancos\u00a0I, Feuchtinger\u00a0A, Chortis\u00a0V, Gilligan\u00a0LC, Ludwig\u00a0P, Riester\u00a0A, Asbach\u00a0E, Hughes\u00a0BA, O\u2019Neil\u00a0DM, Bidlingmaier\u00a0M, Tomlinson\u00a0JW, Hassan-Smith\u00a0ZK, Rees\u00a0DA, Adolf\u00a0C, Hahner\u00a0S, Quinkler\u00a0M, Dekkers\u00a0T, Deinum\u00a0J, Biehl\u00a0M, Keevil\u00a0BG, Shackleton\u00a0CHL, Deeks\u00a0JJ, Walch\u00a0AK, Beuschlein\u00a0F, Reincke\u00a0M (2017) Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism. JCI Insight 2(8):e93136","journal-title":"JCI Insight"},{"key":"1208_CR16","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1210\/jc.2018-00617","volume":"103","author":"C Adolf","year":"2018","unstructured":"Adolf\u00a0C, Kohler\u00a0A, Franke\u00a0A, Lang\u00a0K, Riester\u00a0A, Low\u00a0A, Heinrich\u00a0DA, Bidlingmaier\u00a0M, Treitl\u00a0M, Ladurner\u00a0R, Beuschlein\u00a0F, Arlt\u00a0W, Reincke\u00a0M (2018) Cortisol excess in patients with primary aldosteronism impacts left ventricular hypertrophy. J\u00a0Clin Endocrinol Metab 103:4543\u20134552","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR17","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jc.2019-00996","volume":"104","author":"DA Heinrich","year":"2019","unstructured":"Heinrich\u00a0DA, Adolf\u00a0C, Holler\u00a0F, Lechner\u00a0B, Schneider\u00a0H, Riester\u00a0A, Nirschl\u00a0N, Sturm\u00a0L, Wang\u00a0X, Ladurner\u00a0R, Seidensticker\u00a0M, Bidlingmaier\u00a0M, Beuschlein\u00a0F, Reincke\u00a0M (2019) Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism: long-term outcome and clinical impact. J\u00a0Clin Endocrinol Metab 104:5658\u20135664","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR18","doi-asserted-by":"publisher","DOI":"10.1055\/a-1326-2164","author":"C Lottspeich","year":"2021","unstructured":"Lottspeich\u00a0C, Kohler\u00a0A, Czihal\u00a0M, Heinrich\u00a0DA, Schneider\u00a0H, Handgriff\u00a0L, Reincke\u00a0M, Adolf\u00a0C (2021) Atherosclerotic burden and arterial stiffness are not increased in patients with milder forms of primary aldosteronism compared to patients with essential hypertension. Horm Metab Res. https:\/\/doi.org\/10.1055\/a-1326-2164","journal-title":"Horm Metab Res"},{"key":"1208_CR19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0018","author":"A K\u00f6hler","year":"2021","unstructured":"K\u00f6hler\u00a0A, Sarkis\u00a0AL, Heinrich\u00a0DA, M\u00fcller\u00a0L, Handgriff\u00a0L, Deniz\u00a0S, Schneider\u00a0H, K\u00fcnzel\u00a0H, Ladurner\u00a0R, Reincke\u00a0M, Adolf\u00a0C (2021) Renin a\u00a0marker for left ventricular hypertrophy in primary aldosteronism: a\u00a0cohort study. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-21-0018","journal-title":"Eur J Endocrinol"},{"key":"1208_CR20","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder\u00a0JW, Carey\u00a0RM, Fardella\u00a0C, Gomez-Sanchez\u00a0CE, Mantero\u00a0F, Stowasser\u00a0M, Young\u00a0WF Jr, Montori\u00a0VM, Endocrine\u00a0S (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab 93:3266\u20133281","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR21","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1046\/j.1365-2168.2002.02261.x","volume":"89","author":"M Sywak","year":"2002","unstructured":"Sywak\u00a0M, Pasieka\u00a0JL (2002) Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 89:1587\u20131593","journal-title":"Br J Surg"},{"key":"1208_CR22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","volume":"141","author":"K Hiramatsu","year":"1981","unstructured":"Hiramatsu\u00a0K, Yamada\u00a0T, Yukimura\u00a0Y, Komiya\u00a0I, Ichikawa\u00a0K, Ishihara\u00a0M, Nagata\u00a0H, Izumiyama\u00a0T (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 141:1589\u20131593","journal-title":"Arch Intern Med"},{"key":"1208_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1530\/EJE-19-0138","volume":"181","author":"DA Heinrich","year":"2019","unstructured":"Heinrich\u00a0DA, Adolf\u00a0C, Quinkler\u00a0M, Holler\u00a0F, Lechner\u00a0B, Nirschl\u00a0N, Sturm\u00a0L, Gorge\u00a0V, Beuschlein\u00a0F, Reincke\u00a0M (2019) Safety of medical adjustment and confirmatory testing in the diagnostic work-up of primary aldosteronism. Eur J Endocrinol 181:421\u2013428","journal-title":"Eur J Endocrinol"},{"key":"1208_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fendo.2019.00484","volume":"10","author":"C Sabbadin","year":"2019","unstructured":"Sabbadin\u00a0C, Bordin\u00a0L, Dona\u00a0G, Manso\u00a0J, Avruscio\u00a0G, Armanini\u00a0D (2019) Licorice: from pseudohyperaldosteronism to therapeutic uses. Front Endocrinol (Lausanne) 10:484","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1208_CR25","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams\u00a0B, Mancia\u00a0G, Spiering\u00a0W, Agabiti Rosei\u00a0E, Azizi\u00a0M, Burnier\u00a0M, Clement\u00a0DL, Coca\u00a0A, de Simone\u00a0G, Dominiczak\u00a0A, Kahan\u00a0T, Mahfoud\u00a0F, Redon\u00a0J, Ruilope\u00a0L, Zanchetti\u00a0A, Kerins\u00a0M, Kjeldsen\u00a0SE, Kreutz\u00a0R, Laurent\u00a0S, Lip\u00a0GYH, McManus\u00a0R, Narkiewicz\u00a0K, Ruschitzka\u00a0F, Schmieder\u00a0RE, Shlyakhto\u00a0E, Tsioufis\u00a0C, Aboyans\u00a0V, Desormais\u00a0I, ESC Scientific Document Group (2018) 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart\u00a0J 39:3021\u20133104","journal-title":"Eur Heart J"},{"key":"1208_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00108-021-00972-8","volume":"62","author":"UI Scholl","year":"2021","unstructured":"Scholl\u00a0UI (2021) Hyperaldosteronism. Internist (Berl) 62:245\u2013251","journal-title":"Internist (Berl)"},{"key":"1208_CR27","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1210\/jc.2018-01394","volume":"103","author":"M Stowasser","year":"2018","unstructured":"Stowasser\u00a0M, Ahmed\u00a0AH, Cowley\u00a0D, Wolley\u00a0M, Guo\u00a0Z, McWhinney\u00a0BC, Ungerer\u00a0JP, Gordon\u00a0RD (2018) Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism. J\u00a0Clin Endocrinol Metab 103:4113\u20134124","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR28","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht\u00a0M, Arlt\u00a0W, Bancos\u00a0I, Dralle\u00a0H, Newell-Price\u00a0J, Sahdev\u00a0A, Tabarin\u00a0A, Terzolo\u00a0M, Tsagarakis\u00a0S, Dekkers\u00a0OM (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175:G1\u2013G34","journal-title":"Eur J Endocrinol"},{"key":"1208_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/EJE-11-0287","volume":"165","author":"MJ Betz","year":"2011","unstructured":"Betz\u00a0MJ, Degenhart\u00a0C, Fischer\u00a0E, Pallauf\u00a0A, Brand\u00a0V, Linsenmaier\u00a0U, Beuschlein\u00a0F, Bidlingmaier\u00a0M, Reincke\u00a0M (2011) Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur J Endocrinol 165:301\u2013306","journal-title":"Eur J Endocrinol"},{"key":"1208_CR30","doi-asserted-by":"publisher","first-page":"101400","DOI":"10.1016\/j.beem.2020.101400","volume":"34","author":"M Wolley","year":"2020","unstructured":"Wolley\u00a0M, Thuzar\u00a0M, Stowasser\u00a0M (2020) Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism. Best Pract Res Clin Endocrinol Metab 34:101400","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1208_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams\u00a0TA, Lenders\u00a0JWM, Mulatero\u00a0P, Burrello\u00a0J, Rottenkolber\u00a0M, Adolf\u00a0C, Satoh\u00a0F, Amar\u00a0L, Quinkler\u00a0M, Deinum\u00a0J, Beuschlein\u00a0F, Kitamoto\u00a0KK, Pham\u00a0U, Morimoto\u00a0R, Umakoshi\u00a0H, Prejbisz\u00a0A, Kocjan\u00a0T, Naruse\u00a0M, Stowasser\u00a0M, Nishikawa\u00a0T, Young\u00a0WF Jr, Gomez-Sanchez\u00a0CE, Funder\u00a0JW, Reincke\u00a0M (2017) Primary aldosteronism surgery outcome: I. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5:689\u2013699","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1208_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","volume":"71","author":"GP Rossi","year":"2018","unstructured":"Rossi\u00a0GP, Maiolino\u00a0G, Flego\u00a0A, Belfiore\u00a0A, Bernini\u00a0G, Fabris\u00a0B, Ferri\u00a0C, Giacchetti\u00a0G, Letizia\u00a0C, Maccario\u00a0M, Mallamaci\u00a0F, Muiesan\u00a0ML, Mannelli\u00a0M, Negro\u00a0A, Palumbo\u00a0G, Parenti\u00a0G, Rossi\u00a0E, Mantero\u00a0F, Investigators PS. (2018) Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term. Hypertension 71:585\u2013591","journal-title":"Hypertension"},{"key":"1208_CR33","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.118.10759","volume":"71","author":"DA Calhoun","year":"2018","unstructured":"Calhoun\u00a0DA (2018) Medical versus surgical treatment of primary aldosteronism. Hypertension 71:566\u2013568","journal-title":"Hypertension"},{"key":"1208_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer\u00a0GL, Curhan\u00a0GC, Yozamp\u00a0N, Wang\u00a0M, Vaidya\u00a0A (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a\u00a0retrospective cohort study. Lancet Diabetes Endocrinol 6:51\u201359","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1208_CR35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0215","author":"B Lechner","year":"2019","unstructured":"Lechner\u00a0B, Lechner\u00a0K, Heinrich\u00a0DA, Adolf\u00a0C, Holler\u00a0F, Schneider\u00a0H, Beuschlein\u00a0F, Reincke\u00a0M (2019) THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism. Eur J Endocrinol. https:\/\/doi.org\/10.1530\/EJE-19-0215","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1208_CR36","doi-asserted-by":"publisher","first-page":"e4382","DOI":"10.1210\/clinem\/dgaa634","volume":"105","author":"Y Yang","year":"2020","unstructured":"Yang\u00a0Y, Williams\u00a0TA, Song\u00a0Y, Yang\u00a0S, He\u00a0W, Wang\u00a0K, Cheng\u00a0Q, Ma\u00a0L, Luo\u00a0T, Yang\u00a0J, Reincke\u00a0M, Burrello\u00a0J, Li\u00a0Q, Mulatero\u00a0P, Hu\u00a0J (2020) Nomogram-based preoperative score for predicting clinical outcome in unilateral primary aldosteronism. J\u00a0Clin Endocrinol Metab 105(12):e4382\u2013e4392","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1208_CR37","doi-asserted-by":"publisher","first-page":"dgaa379","DOI":"10.1210\/clinem\/dgaa379","volume":"105","author":"J Burrello","year":"2020","unstructured":"Burrello\u00a0J, Burrello\u00a0A, Pieroni\u00a0J, Sconfienza\u00a0E, Forestiero\u00a0V, Rabbia\u00a0P, Adolf\u00a0C, Reincke\u00a0M, Veglio\u00a0F, Williams\u00a0TA, Monticone\u00a0S, Mulatero\u00a0P (2020) Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism. J\u00a0Clin Endocrinol Metab 105(10):dgaa379","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR38","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1210\/jc.2015-3431","volume":"101","author":"T Abe","year":"2016","unstructured":"Abe\u00a0T, Naruse\u00a0M, Young\u00a0WF Jr, Kobashi\u00a0N, Doi\u00a0Y, Izawa\u00a0A, Akama\u00a0K, Okumura\u00a0Y, Ikenaga\u00a0M, Kimura\u00a0H, Saji\u00a0H, Mukai\u00a0K, Matsumoto\u00a0H (2016) A novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism. J\u00a0Clin Endocrinol Metab 101:1008\u20131015","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"Heinze\u00a0B, Fuss\u00a0CT, Mulatero\u00a0P, Beuschlein\u00a0F, Reincke\u00a0M, Mustafa\u00a0M, Schirbel\u00a0A, Deutschbein\u00a0T, Williams\u00a0TA, Rhayem\u00a0Y, Quinkler\u00a0M, Rayes\u00a0N, Monticone\u00a0S, Wild\u00a0V, Gomez-Sanchez\u00a0CE, Reis\u00a0AC, Petersenn\u00a0S, Wester\u00a0HJ, Kropf\u00a0S, Fassnacht\u00a0M, Lang\u00a0K, Herrmann\u00a0K, Buck\u00a0AK, Bluemel\u00a0C, Hahner\u00a0S (2018) Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma. Hypertension 71:317\u2013325","journal-title":"Hypertension"},{"key":"1208_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11906-019-0985-0","volume":"21","author":"F Holler","year":"2019","unstructured":"Holler\u00a0F, Heinrich\u00a0DA, Adolf\u00a0C, Lechner\u00a0B, Bidlingmaier\u00a0M, Eisenhofer\u00a0G, Williams\u00a0TA, Reincke\u00a0M (2019) Steroid profiling and immunohistochemistry for subtyping and outcome prediction in primary aldosteronism\u2014a review. Curr Hypertens Rep 21:77","journal-title":"Curr Hypertens Rep"},{"key":"1208_CR41","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","volume":"72","author":"LS Meyer","year":"2018","unstructured":"Meyer\u00a0LS, Wang\u00a0X, Susnik\u00a0E, Burrello\u00a0J, Burrello\u00a0A, Castellano\u00a0I, Eisenhofer\u00a0G, Fallo\u00a0F, Kline\u00a0GA, Knosel\u00a0T, Kocjan\u00a0T, Lenders\u00a0JWM, Mulatero\u00a0P, Naruse\u00a0M, Nishikawa\u00a0T, Peitzsch\u00a0M, Rump\u00a0LC, Beuschlein\u00a0F, Hahner\u00a0S, Gomez-Sanchez\u00a0CE, Reincke\u00a0M, Williams\u00a0TA (2018) Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism. Hypertension 72:650\u2013657","journal-title":"Hypertension"},{"key":"1208_CR42","doi-asserted-by":"publisher","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","volume":"3","author":"G Eisenhofer","year":"2020","unstructured":"Eisenhofer\u00a0G, Duran\u00a0C, Cannistraci\u00a0CV, Peitzsch\u00a0M, Williams\u00a0TA, Riester\u00a0A, Burrello\u00a0J, Buffolo\u00a0F, Prejbisz\u00a0A, Beuschlein\u00a0F, Januszewicz\u00a0A, Mulatero\u00a0P, Lenders\u00a0JWM, Reincke\u00a0M (2020) Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism. JAMA Netw Open 3:e2016209","journal-title":"JAMA Netw Open"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-021-01208-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T11:02:59Z","timestamp":1642158179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-021-01208-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-01208-5","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"assertion":[{"value":"27 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.T.\u00a0Fuss, S.\u00a0Hahner, D.A.\u00a0Heinrich und C.\u00a0Adolf geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}